CompletedPhase 4

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

China118 participantsStarted 2015-11

Plain-language summary

The purpose of this clinical multi-center study is to determine whether different doses of domperidone are effective in the treatment of feeding intolerance in premature infant

Who can participate

Age range20 Weeks – 35 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * the residual milk and glucose over 55% * abdominal distention or vomiting; * Reduce,delay or disruption of enteral feeding Exclusion Criteria: * Four weeks before the start of this study had participated in other clinical trials * pulmonary hypertension; * Infants with necrotizing enterocolitis * Gastrointestinal tract malformation, congenital heart disease * Pre-existing QT extend/between long QT syndrome; * ascites * Have been used or will use drugs suppress CYP3A4 * Other risk factors for prolong the QT

What they're measuring

the residual glucose percentage

Timeframe: 7 days

Trial details

NCT IDNCT02980250

SponsorNanfang Hospital, Southern Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05

View on ClinicalTrials.gov More Feeding Intolerance trials